Susquehanna International Group
UTMD icon

Susquehanna International Group’s Utah Medical Products UTMD Stock Holding History

Susquehanna International Group’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,814
Closed -$274K – 13976
2025
Q2 		$274K Sell
4,814
-383
-7% -$20.8K ﹤0.01% 10553
2025
Q1 		$291K Buy
+5,197
New +$311K ﹤0.01% 10124
2020
Q4 		– Sell
-7,207
Closed -$576K – 11772
2020
Q3 		$576K Sell
7,207
-20,953
-74% -$1.74M ﹤0.01% 7385
2020
Q2 		$2.5M Buy
+28,160
New +$2.53M ﹤0.01% 4103
2017
Q1 		– Sell
-5,356
Closed -$390K – 10025
2016
Q4 		$390K Buy
+5,356
New +$348K ﹤0.01% 7465

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Susquehanna International Group's UTMD Position: Q3 2025 in Review

Susquehanna International Group sold out of Utah Medical Products (UTMD) in Q3 2025, closing a stake of 4,814 shares — an estimated $274K sold.

Susquehanna International Group first reported a position in UTMD in Q4 2016 and held it in 5 quarters. The position peaked at $2.5M in Q2 2020. 117 funds tracked by Wall St. Rank hold UTMD as of Q3 2025.

  • Susquehanna International Group reported no remaining Utah Medical Products position as of Q3 2025 after selling out during the quarter.
  • Susquehanna International Group sold 4,814 Utah Medical Products shares in Q3 2025, an estimated $274K.
  • Susquehanna International Group first reported a position in Utah Medical Products in Q4 2016 and held it in 5 quarters.
  • Susquehanna International Group's Utah Medical Products position peaked at $2.5M in Q2 2020.
  • 117 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.